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Zebrafish biosensor for toxicant 
induced muscle hyperactivity
Maryam Shahid1,5,*, Masanari Takamiya1,*, Johannes Stegmaier3,*, Volker Middel1,5, 
Marion Gradl1, Nils Klüver4, Ralf Mikut3, Thomas Dickmeis1, Stefan Scholz4, 
Sepand Rastegar1, Lixin Yang1,2 & Uwe Strähle1,5
Robust and sensitive detection systems are a crucial asset for risk management of chemicals, which are 
produced in increasing number and diversity. To establish an in vivo biosensor system with quantitative 
readout for potential toxicant effects on motor function, we generated a transgenic zebrafish line 
TgBAC(hspb11:GFP) which expresses a GFP reporter under the control of regulatory elements of the 
small heat shock protein hspb11. Spatiotemporal hspb11 transgene expression in the musculature 
and the notochord matched closely that of endogenous hspb11 expression. Exposure to substances 
that interfere with motor function induced a dose-dependent increase of GFP intensity beginning at 
sub-micromolar concentrations, while washout of the chemicals reduced the level of hspb11 transgene 
expression. Simultaneously, these toxicants induced muscle hyperactivity with increased calcium spike 
height and frequency. The hspb11 transgene up-regulation induced by either chemicals or heat shock 
was eliminated after co-application of the anaesthetic MS-222. TgBAC(hspb11:GFP) zebrafish embryos 
provide a quantitative measure of muscle hyperactivity and represent a robust whole organism system 
for detecting chemicals that affect motor function.
The increasing diversity of chemicals produced by industry generates concerns regarding the potential hazards on 
biota and human health. The European Union’s REACH (Registration, Evaluation, Authorization and Restriction 
of Chemicals) regulation declares that the commercial producers are responsible for risk assessment and manage-
ment of the chemicals that they produce. A major emphasis is placed on chemical safety requiring the evaluation 
of potential adverse toxicological outcomes and ecotoxicological hazards prior to selling the chemicals. Embryos 
of zebrafish (Danio rerio) were shown to be efficient for such toxicological estimation showing, for instance, a 
correlation and equal sensitivity to acute fish toxicity1,2.
Molecular endpoints derived from toxicogenomic responses provided other endpoints that allow us to 
demonstrate the presence of compounds with a specific, potentially tissue-specific mode of action3–6. This obser-
vation has led to the development of transgenic biosensor lines that utilize genetic regulatory elements to drive 
the expression of fluorescent proteins and thereby report the presence of target classes of substances in the envi-
ronment, such as estrogenic compounds7–10, dioxins11, heavy metals12–14, goitrogens15 and glucocorticoids16–18. 
Interestingly, many of these biosensor genes exhibit tissues preferably responsive to particular classes of pollut-
ants6. Although there are approaches using tissue-specific fluorescent reporter lines for the testing of chemical 
compound effects on, for instance, the heart, blood vessels, central nervous system and pancreas19, interpreta-
tion of results may not be straightforward. Many substances affect motility and thereby indirectly survival. This 
prompted us to develop a biosensor system that provides simple and quantifiable readouts for effects of chemicals 
on the skeletal musculature that combines physiological with behavioural readouts.
Heat shock proteins (HSPs) are known for their immediate responses upon exposure to a wide range of chem-
ical stressors with little dependency on chemical structures3,13. Interestingly, we found that one of the vertebrate 
HSP family genes, hspb11, becomes up-regulated specifically by chemicals that interfere with motor function20. 
The up-regulation was discussed as a potentially protective response upon over-excitation of the muscle and 
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increase of intracellular Ca2+ levels in the muscle cells. We therefore investigated whether hspb11 gene regulatory 
elements can be used to build a biosensor to detect chemicals that impair motor function.
Motor dysfunction can be caused by problems in motor neurons and/or in the muscle. At the neuromuscular 
junction, a neurotransmitter, acetylcholine (ACh), is released from pre-synaptic terminals of motor neurons. 
Upon ACh binding to the post-synaptic nicotinic ACh receptor complex, the membrane of the muscle end plate 
depolarizes rapidly. This depolarization activates a cluster of voltage-gated sodium channels at the neuromuscu-
lar junctions and converts local end plate depolarization into a muscle fibre-wide action potential21. The action 
potential triggers a cascade of events that leads to muscle contraction, mediated by transient release of calcium 
ions from the sarcoplasmic reticulum. Because chemical interference with each of these distinct processes affects 
motility, we require assays which report the mode of action.
We report here that the bacterial artificial chromosome (BAC) transgenic zebrafish TgBAC(hspb11:GFP) line 
specifically responded to chemicals that interfere with motor function and that cause induction of muscle hyper-
activity. Dose-dependent up-regulation of hspb11 transgene expression was observed with a structurally wide 
range of chemicals and correlated with motility defects. We demonstrate that hspb11 transgene expression is 
induced specifically by muscle hyperactivity irrespective of the state of muscle integrity.
Results
A zebrafish hspb11 BAC transgenic line recapitulates the expression of the endogenous 
gene. We previously reported that hspb11 transcription was significantly induced by the pesticide, azinphos-
methyl which impairs muscle integrity20. As no biosensor system was available for in vivo detection of chemi-
cals causing motor dysfunction, we aimed at developing a transgenic zebrafish reporter line recapitulating the 
basal and induced expression patterns of hspb11. For this purpose, we obtained a BAC clone that includes the 
hspb11 locus and inserted a GFP reporter into the single exon locus of hspb11 by homologous recombination in 
E. coli22,23. To facilitate the insertion of the recombined BAC fragment with GFP reporter into the zebrafish 
genome, we also introduced the iTol2 cassette into the BAC backbone for Tol2 transposase mediated insertion24.
The established TgBAC(hspb11:GFP) transgenic line recapitulated the endogenous hspb11 expression pattern 
throughout embryonic development. At 24 hours post-fertilization (hpf), GFP-positive cells were detected in 
muscle pioneer cells at 24 hpf (Fig. 1A–A’, big arrow). At 48 hpf, the hspb11 transgene is expressed in the slow 
muscles (Fig. 1B–B’, sm). Robust expression of the GFP reporter was also seen in the notochord at 48 hpf and later 
stages (Fig. 1B–B’, b and C–C’, c). At 5 days post-fertilization (dpf), GFP was detected in slow muscle fibres, the 
notochord, the heart, jaw and eye muscles and pectoral fins (Fig. 1C–C’). This expression pattern of the hspb11 
transgene is consistent with the endogenous hspb11 gene expression pattern (Fig. 1D–G). Moreover, heat shock 
activated expression of the transgene mRNA in slow and fast muscles to a similar levels as the endogenous hspb11 
gene (data not shown). Thus, we established a TgBAC(hspb11:GFP) line that faithfully reflects the endogenous 
gene expression with correct spatial and temporal distribution.
The hspb11 transgene responses to pesticides. To test whether the transgene expression is respon-
sive to compounds that cause muscle toxicity, we treated TgBAC(hspb11:GFP) embryos with azinphosmethyl, 
propoxur and galanthamine, which exert their toxic effects on muscle through inhibition of Acetylcholine ester-
ase (AChE) activity20. Embryos were exposed to the three pesticides from the 90%-epiboly stage (9 hpf) to 48 
hpf. Treatments with all three compounds caused an up-regulation of GFP expression in the slow muscle (sm, 
Fig. 2F,I,L) and also in the notochord (n, Fig. 2F,I,L) compared with a negative control treated with 0.1% (v/v) 
DMSO only (Fig. 2C). To assess muscle fibre arrangement or integrity under these treatments, we examined 
birefringence of the muscles. We observed that all chemicals also caused a reduction in muscle birefringence, 
consistent with their previously described effects and paralleling the transgene response. The magnitude of the 
transgene expression was roughly proportional to the loss of muscle integrity observed via the assessment of 
birefringence. We also assessed whether transgene activation is restricted to slow muscle by in situ hybridisation 
of azinphosmethyl treated and DMSO control embryos. An increase of gfp mRNA was detected in both slow and 
fast muscles in azinphosmethyl treated embryos but not solvent controls (data not shown).
To further ask whether the transgene expression level correlates with the reduced muscle integrity, we exam-
ined whether the transgene expression level would be reversed after recovery of muscle integrity by washing 
the compounds off. We compared GFP reporter levels between two groups for each of the three chemicals; one 
group treated with the chemical from 9–48 hpf, while another group treated from 9–24 hpf, followed by several 
washes in fresh fish water until 48 hpf (Fig. 2M–T). For all chemical treatments, washout of the chemicals led 
to higher birefringence (Fig. 2N–S). This recovery of muscle integrity after the washout of the compounds was 
accompanied by a reduction of hspb11 transgene expression levels (Fig. 2T, one-way ANOVA, p = 1.228 × 10−14). 
Consistent with a partial and not full recovery of muscle integrity assessed by birefringence, hspb11 transgene 
levels after the washout were higher than those of DMSO negative control for two of the three chemical treat-
ments (Fig. 2T; one-way ANOVA, p = 3.09 × 10−14; TukeyHSD test, p = 0.0000000 for azinphosmethyl vs. control, 
p = 0.0507833 for propoxur vs. control, and p = 0.0124261 for galanthamine vs. control).
The hspb11 transgene was specifically induced by chemicals that impair muscle integrity in a 
dose-dependent manner. We tested whether the hspb11 transgene responds in a dose-dependent manner. 
We quantified the GFP reporter intensity in the trunk region (slow muscle + notochord) of TgBAC(hspb11:GFP) 
embryos after treatments with 14 test chemicals that have previously been shown to impair motor function. These 
chemicals exert their motor-toxic effects through inhibition of AChE, modulation of channel properties or other 
pathways (Table S1 and Fig. S3). All these chemicals induced impaired motility in a touch response assay (Table S2, 
Fig. S1). This was not simply due to general lethality, since impaired motility occurred already at doses well below 
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Figure 1. Zebrafish hspb11 BAC transgenic line recapitulates the endogenous gene expression. Expression of 
the hspb11 transgene (GFP, green) at 24 hpf (A–A’), 48 hpf (B–B’) and 5 dpf (C–C’). Lateral views are shown with 
the anterior end oriented to the left. Insets (a-c) show optical transverse sections, dorsal side up. Fluorescence 
channel image of the hspb11 reporter (A–C) is merged with the respective bright field transmission images 
(A’–C’). (A–A’) hspb11 transgenic embryos at 24 hpf show GFP reporter expression in the muscle cells (big 
arrow) in a layer of slow muscles (inset a, small arrow). A stippled circle in the inset (a) represents the notochord. 
(B–B’) At 48 hpf, stronger GFP expression appears in the notochord (nc, also inset b dotted circle) and in the 
slow muscle cells (sm; a small arrow in the inset b). (C–C’) At 5 dpf the GFP expression in slow muscle cells (sm) 
and notochord (nc) persists, with additional expressions in the heart (h), eye muscles (em), pectoral fins (pf), jaw 
muscles (jm) and weakly in the fast muscles (c, arrowhead). (D–G) In situ gene expression analysis of hspb11 at 
24 (D) and 48 hpf (E–G) in wildtype embryos. At 24 hpf, hspb11 expression appears in the muscle pioneer cells 
(D, white arrow), and it is further expressed in the slow muscles at 48 hpf (F, sm). (E) At 48 hpf hspb11 expression 
is also seen in the muscle of the eye (em), the jaw muscles (jm) and in the heart (h). (G) hspb11 expression is 
visible in the notochord at 48 hpf. Scale bar: (A–C’) 200 μm, (D–G) 100 μm.
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Figure 2. The hspb11 transgene responses to pesticides. Embryos from TgBAC(hspb11:GFP) were treated 
with either DMSO (solvent control; A–C and M), or the pesticides azinphosmethyl (APM; D–F), propoxur 
(PPX; G–I) or galanthamine (GAL; J–L). The embryos were treated from 90%-epiboly (9 hpf) to 48 hpf and 
examined for birefringence as a readout of muscle integrity (B,E,H,K; lateral view of the trunk region) and 
hspb11 transgene expression (C,F,I,L; dorsal view of the trunk region). Corresponding bright field images 
are given in (A,D,G,J; lateral view). The stippled lines (in C,F,I,L) delineate the notochord (n). sm: slow 
muscle. Anterior left. (M–S) Embryos from TgBAC(hspb11:GFP) were treated with either azinphosmethyl 
(N,O), propoxur (P,Q) or galanthamine (R,S). The hspb11 transgene level was compared between two 
groups: one group treated with chemicals from 9–48 hpf (“not washed”; M,N,P,R), another treated from 9–24 
hpf, followed by several washes in fresh fish water until 48 hpf (“washed”; O,Q,S). The intensity of hspb11 
transgene is expressed in fold increase over control. Scale bars: (A,B,D,E,G,H,J,K,M–S) 100 μm; (C,F,I,L) 
50 μm. (T) Quantification of the experiments exemplified in (M–S). The intensity of hspb11 transgene 
expression is shown as fold induction over DMSO control. There were significant effects of the washout of 
the compounds on the hspb11 transgene level (one-way ANOVA, F[1, 118] = 77.762, p = 1.228 × 10−14), 
with azinphosmethyl (TukeyHSD test from here onward, p = 0.0000000), propoxur (p = 0.0000429), and 
galanthamine (p = 0.0000087) treated embryos now showing lower hspb11 transgene expression. However, all 
washed groups showed still higher hspb11 transgene levels in comparison to DMSO solvent control (one-way 
ANOVA, F[3, 118] = 29.316, p = 3.09 × 10−14; TukeyHSD test, ***p = 0.0000000 for azinphosmethyl vs. control, 
p = 0.0507833+ with a substantial difference for propoxur vs. control, and *p = 0.0124261 for galanthamine vs. 
control).
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Figure 3. Dose-dependent and chemical-specific up-regulation of hspb11 transgene expression. Embryos 
from TgBAC(hspb11:GFP) were treated with the following chemicals: azinphosmethyl (A), propoxur (B), 
galanthamine (C), chlorpyrifos (D) and dibutylphthalate (E), veratridine (F), methylmercury (G), flucythrinate 
(H), esfenvalerate (I), methoxychlor (J) and chlorophenol (K), dibromoethane (L), dimethylphenol (M) and 
chlorothalonil (N). The hspb11 reporter levels were expressed in fold induction over control as a function of 
nominal chemical concentration (μM). Concentration dependent responses to the chemicals with up-regulation 
of the hspb11 reporter level (one-way ANOVA p < 0.001) were modelled using a logarithmic Gaussian model, 
except methylmercury, dibutylphthalate, methoxychlor and 4-chlorophenol for which a linear model was 
used. The hspb11 transgene level 1.5-fold increased over control is indicated by stippled horizontal lines in 
red. The EC1.5 dose (vertical stippled red lines) and modelled concentration-response curves (blue) were 
overlaid on the individual data points with mean (black circle) and standard deviation (vertical black bar) 
shown at each dose. The EC1.5 values of methoxychlor and dibutylphthalate in parenthesis are estimated values 
from linear modelling. Albeit their significant hspb11 transgene responses, flucythrinate and esfenvalerate 
were not efficiently modelled (one-way ANOVA, F(3, 116) = 6.1961, p = 6.0 × 10−4, F(3, 117) = 26.0963, 
p = 5.369 × 10−13, respectively). One-way ANOVA values for the rest are the following: azinphosmethyl, 
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the LC50 (Table S2, Fig. S2). We exposed the TgBAC(hspb11:GFP) embryos to these chemicals from 9–48 hpf and 
performed a semi-automatic quantitative assessment of GFP reporter intensity25.
AChE inhibitors impair muscle function by preventing the degradation of ACh at the neuromuscular junc-
tion. Genetic mutation of AChE function in the zebrafish severely disrupts muscle integrity as a result of muscle 
hyperactivity, and it also increases hspb11 expression20,26. In line with these findings, a dose-responsive increase 
of hspb11 transgene expression was detected after exposure of embryos to the AChE inhibitors azinphosmethyl, 
propoxur27, galanthamine, and chlorpyrifos (Fig. 3A–D). Consistent with the reported weak AChE inhibiting 
effect of dibutylphthalate28, we observed only weak effects on hspb11 transgene expression in embryos exposed 
to this compound (Fig. 3E, Table S1). The effective concentrations that achieved 1.5-fold increase over control 
(EC1.5) varied from sub-micromolar to millimolar scale (Fig. 3A–E; Table S2), in good dosage agreement with 
impaired motility, particularly for the compounds which have effects on hspb11 expression already well below 
lethality as the apical endpoint (Fig. S1; Table S2).
Ion channels are often targets of medicines and toxicants. Normal motor function requires precise control of 
voltage-gated Na+ channel function for the transformation of focal membrane depolarization into a fibre-wide 
action potential and the ensuing release of intracellular calcium ions for actin-myosin interaction. We examined 
the effects of voltage-gated Na+ channel activators (veratridine, flucytrinate and esfenvalerate), of methylmercury 
that causes up-regulation of intracellular calcium levels, and of other channel modulators (methoxychlor and 
chlorophenol) (Fig. 3F–K). For all channel modulators, we observed dose-dependent up-regulation of hspb11 
transgene expression, again in good dosage agreement with impaired motility (Fig. S1; Table S2). Channel mod-
ulator treatment led to reduced muscle integrity as well (Fig. 4F–K). Thus, hspb11 transgene up-regulation was 
again found to correlate with motor dysfunction, as we observed with AChE inhibitors.
To confirm the specificity of the hspb11 transgene response as an indicator of motor dysfunction, we also 
tested some other compounds with no previously reported effects on muscle birefringence in treated embryos: 
dibromoethane (oxidative phosphorylation disruptor), dimethylphenol (disruptor of ATPase activity) and chlo-
rothalonil (thiol-reactive) (Fig. 4L–N). The hspb11 transgene levels were not significantly different from solvent 
control after treatments with the three compounds (Fig. 3L–N, one-way ANOVA p > 0.001). Importantly, all 
three chemicals induced impaired motility (Fig. S1L–N), while none of them showed reduction in muscle integ-
rity (Fig. 4L–N). Given the mode of action of these compounds (interference with energy metabolism, Table 
S1), the reduction of motility could be related to the depletion of the cellular energy storage and subsequent 
inability to conduct muscle contraction. In contrast, AChE inhibitors or sodium channel activators would lead to 
an over-excitation of muscles and impairment of motility due to increased muscle activity. The far lower hspb11 
EC1.5 concentrations in comparison to corresponding LC50 values observed with propoxur (37.8-fold lower) 
and chlorpyrifos (19.5-fold) further indicate the specificity of hspb11 transgene response (Table S2). Taken 
together, the hspb11 transgene system detected the presence of chemicals of a wide range of structures which 
cause impaired muscle integrity.
hspb11 reporter induction accompanies muscle hyperactivity. To correlate muscle physiology more 
directly with hspb11 up-regulation, we established a muscle specific Ca2+ biosensor line Tg([-505/-310]unc45b:G-
CaMP5A). We put the GCaMP5a cassette29 under the control of regulatory elements of the unc45b gene (Etard 
et al., unpublished), which confer skeletal muscle-specific reporter gene expression (Fig. 5A–B). We exposed 
embryos at 72 hpf with solvent control, with chemicals that induce hspb11 transgene expression (azinphosme-
thyl, propoxur, galanthamine and veratridine; Fig. 3A–C,F) and with dibromoethane, which does not induce 
hspb11 transgene expression (Fig. 3L), and measured Ca2+ fluctuations under a confocal microscope for 16 hours 
(Fig. 5C–H). To quantify the effects of chemicals on the dynamics of Ca2+ fluctuations, we compared the height 
of the Ca2+ peaks (Fig. 5I) as well as the time intervals between two adjacent Ca2+ peaks (Fig. 5J). In compar-
ison with the control treatment, exposure to azinphosmethyl and galanthamine led to a significant increase in 
the height of calcium spikes (**p < 0.01, Fig. 5I). Similar effects were observed with propoxur and veratridine 
(*p < 0.05, Fig. 5I). In terms of the frequency of the calcium spikes, significantly reduced time intervals were 
observed with azinphosmethyl and veratridine in comparison to the control (**p < 0.01, Fig. 5J). Dibromoethane, 
which does not induce hspb11 transgene expression (Fig. 3L), showed no effects on the calcium dynamics com-
pared to the control group (Fig. 5I–J). These increases of calcium spike intensity and frequency are hallmarks of 
muscle hyperactivity. Thus, we identified induction of muscle hyperactivity as a common feature of chemicals that 
up-regulate the hspb11 transgene.
Chemically induced up-regulation of hspb11 transgene requires muscle hyperactivity. The 
hspb11 transgene up-regulation occurs concomitantly with muscle hyperactivity (Figs 3 and 5). This raises the 
question whether it is the hyperactivity per se that causes the up-regulation of hspb11 transgene expression, irre-
spective of the state of muscle integrity. To address this question, we examined whether up-regulation of hspb11 
transgene expression is suppressed when muscle contraction is abolished by an anaesthetic.
F(9, 310) = 44.3539, p = 1.121 × 10−50; propoxur, F(9, 278) = 51.1080, p = 6.485 × 10−54; galanthamine, F(7, 
245) = 56.6725, p = 9.363 ×  × 10−48; chlorpyrifos, F(3, 121) = 68.4166, p = 6.111 × 10−26; di-n-butylphthalate, 
F(3, 121) = 25.4847, p = 7.555 × 10−13; veratridine, F(8, 280) = 29.0567, p = 8.135 × 10−33; methylmercury,  
F(3, 118) = 58.4852, p = 3.071 × 10−23; methoxychlor, F(3, 119) = 21.7458, p = 2.681 × 10−11; 4-chlorophenol, 
F(3, 107) = 12.2473, p = 5.969 × 10−7; 1,2-dibromoethane, F(3, 109) = 0.3508, p = 0.788; 2,4-dimethylphenol, 
F(3, 121) = 4.5156, p = 4.0 × 10−3; chlorothalonil, F(3, 117) = 2.0164, p = 0.115.
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Figure 4. Reduced muscle integrity in correlation to hspb11 transgene up-regulation. Birefringence images 
from the trunk region of wildtype embryos, treated during 9–48 hpf with either azinphosmethyl (A, 3 μM), 
propoxur (B, 720 μM), galanthamine (C, 1 mM), chlorpyrifos (D, 20 μM), dibutylphthalate (E, 2.69 μM), 
veratridine (F, 120 μM), methylmercury (G, 0.119 μM), methoxychlor (H, 2.3 μM), esfenvalerate (I, 0.191 µM), 
flucythrinate (J, 0.055 µM), chlorophenol (K, 389 μM), dibromoethane (L, 2.1 mM), dimethylphenol (M, 327 μM) 
and chlorothalonil (N, 0.4 μM). Five representative examples are shown for each chemical. Scale bar: 500 μm.
www.nature.com/scientificreports/
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Figure 5. Up-regulation of hspb11 transgene accompanies muscle hyperactivity. (A,B) Lateral views of 
the trunk region of a muscle-specific calcium sensor line Tg([-505/-310]unc45b:GCaMP5A) at 72 hpf. The 
fluorescent channel images for calcium (green) are merged with the bright field transmission images (gray) for 
non-contractile resting state (A) and excitatory state (B), exhibiting low and high fluorescent reporter levels, 
respectively. Anterior side is oriented to the left. Scale bar: 50 μm. (C–H) Profiles of calcium levels in the trunk 
skeletal muscle from individual embryos treated with either DMSO solvent control (Ctrl, C), dibromoethane 
(DBE, D), azinphosmethyl (APM, E), propoxur (PPX, F), galanthamine (GAL, G) or veratridine (VER, H) 
plotted as a function of time (temporal resolution: 2.5 minutes). The number of examined embryos is shown 
at the top-right of each panel. (I–J) Calcium profiles shown in the panels (C–H) were analyzed for the height 
of individual calcium spikes (I) and the temporal interval of two adjacent calcium spikes (J) and presented in 
whisker-box charts with individual data shown as gray dots. Black dots represent outliers. (I) One-way ANOVA 
showed significant differences of calcium spike height (F[5,315] = 4.1464, p = 0.00116) between solvent control 
(n = 55 spikes), dibromoethane (n = 16 spikes), azinphosmethyl (n = 89 spikes), propoxur (n = 45 spikes), 
galanthamine (n = 20 spikes), veratridine (n = 96 spikes). Significant differences over the solvent control were 
found with azinphosmethyl (TukeyHSD test from here onward, **p = 0.002698), propoxur (*p = 0.01845), 
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For chemical induction of hspb11 transgene expression, we used azinphosmethyl (3 μM), propoxur (720 μM), 
galanthamine (1 mM) and veratridine (120 μM), with DMSO (0.05%) and dibromoethane (2.1 mM) as negative 
controls (Fig. 3). In the absence of the anaesthetic MS-222 (tricaine methanesulfonate, 643 μM), we observed 
significant up-regulation of hspb11 transgene in treatments with all four compounds in comparison to the respec-
tive solvent controls (Fig. 6A; ***p < 0.001, Tukey honest significant difference (HSD) test). Co-exposure with 
MS-222, however, abolished the up-regulation of hspb11 transgene expression by these compounds (Fig. 6A, 
p = 0.05185 one-way ANOVA), suggesting that muscle contraction is required for the up-regulation of the hspb11 
transgene.
Next, we examined whether there is still a correlation between hspb11 up-regulation and muscle disintegra-
tion when muscle contraction is absent. As reported previously30, we observed reduced muscle integrity even with 
solvent-control embryos when they were raised in the presence of MS-222 (Fig. 6B’), reflecting the adverse effects 
of MS-222 on the development of the somite (data not shown). Although we observed similarly reduced muscle 
integrity after exposure to MS-222 with or without chemicals (Fig. 6B’–G’), we did not observe up-regulation 
of the hspb11 transgene with any of the treatments (Fig. 6A). Thus, in the absence of muscle contraction hspb11 
transgene levels do not correlate with reduced muscle integrity, indicating again the requirement of muscle activ-
ity for the up-regulation of the hspb11 transgene.
Up-regulation of hspb11 transgene expression by heat shock is also caused by muscle hyper-
activity. We observed that hspb11 transgene expression appears to be up-regulated by muscle hyperactivity, 
but not necessarily by muscle disintegration (Fig. 6A–G’). Thus, conditions should exist where hspb11 transgene 
expression is up-regulated in the absence of muscular disintegration. To test this hypothesis, we selected heat 
shock as a means for fine controlling hspb11 transgene induction and explored heat shock conditions that do not 
cause muscle disintegration. A heat shock at 37 °C for 1 hour did not reduce muscle integrity of treated embryos 
at 48 hpf; 97% embryos (n = 31) showed normal birefringence (Fig. 6I), comparable to the control group without 
heat shock (n = 30 [97%], Fig. 6H). We applied this heat shock condition to TgBAC(hspb11:GFP) embryos at 48 
hpf and measured hspb11 transgene levels at 4–5 hours after the heat shock.
In the absence of MS-222, the heat shock treatment significantly increased hspb11 transgene levels at both 24 
hpf (data not shown) and 48 hpf (Fig. 6J; ***p < 0.001, Welch two sample t-test). In the presence of MS-222 during 
the 1-hour period of heat shock, however, up-regulation of hspb11 transgene expression was eliminated at both 
stages of development (Fig. 6J’, p = 0.7098). This indicates that hspb11 transgene expression was up-regulated not 
by the heat itself, but rather by muscle hyperactivity during the heat shock. Accordingly, we observed increased 
motility during heat shock treatment in the absence of MS-222 (data not shown). Importantly, we did not observe 
muscle disintegration in the presence of MS-222 for 1-hour with or without heat shock; for each group n = 29/30 
[97%] embryos showed normal birefringence. This result supports our hypothesis that it is not reduced muscle 
integrity but rather its hyperactivity that causes the up-regulation of hspb11 transgene expression.
Discussion
We report here that we established a transgenic zebrafish line TgBAC(hspb11:GFP) as a tool for monitoring chem-
icals that induce muscle hyperactivity. This transgenic line does not require time-lapse analysis for detecting 
muscle hyperactivity, as it converts a dynamic process into a quantifiable single readout. Because it does not 
assume any particular class of chemical compounds, it provides robust detection power. Indeed, chemicals that 
up-regulate hspb11 transgene expression show a wide variety of chemical structures (Fig. 3). This transgenic line 
detects chemicals that modify normal neuromuscular transmission between motor neurons and muscle fibres. 
Therefore, it may not detect chemicals that interfere with higher motor function without inducing muscle hyper-
activity, which is integrated with sensory system and/or cognitive function (e.g. locomotion, social behaviour).
One criticism against using heat shock proteins for any biosensor is the potential of a high false positive 
rate through their responsiveness to a wide range of stresses, such as heat shock or ROS exposure. However, 
our results show that the hspb11 transgene specifically responds to muscle hyperactivity; a heat shock does not 
induce its expression if muscle activity is inhibited in parallel (Fig. 6). In zebrafish, there are 13 sHSPs, and five 
of them (hspb1, hspb7, hspb8, hspb9 and hspb11) are expressed in the muscle, where they show induced expres-
sion upon heat shock31,32. Our finding that hspb11 transgene expression responds to muscle hyperactivity rather 
than directly to the heat shock raises the possibility that these “heat shock-inducible” sHSPs expressed in the 
muscle may also primarily respond to muscle hyperactivity. This unique hyperactivity-dependent hspb11 trans-
gene induction precludes false-positive responses arising from general stresses associated with sample handling 
during a chemical screen. The high signal-to-noise ratio of up to 3-fold of GFP intensity after toxicant exposure is 
another beneficial feature of our hspb11-based system.
If hspb11 transgene expression is regulated in a muscle activity-dependent manner, how should one interpret 
its expression in the notochord? Is our strategy to combine both muscular and notochordal hspb11 transgene 
galanthamine (**p = 0.009827) and veratridine (*p = 0.01391) treatments, while dibromoethane showed 
no difference over the control treatment (p = 0.9317). (J) Significant differences of calcium spike intervals 
were detected (one-way ANOVA, F[5,256] = 12.422, p = 8.405 × 10−11) between solvent control (n = 42 
intervals), dibromoethane (n = 12 intervals), azinphosmethyl (n = 75 intervals), propoxur (n = 34 intervals), 
galanthamine (n = 16 intervals), veratridine (n = 83 intervals). Azinphosmethyl (TukeyHSD test from here 
onward, **p = 0.003285) and veratridine (***p = 1.0 × 10−7) treatments significantly shortened the interval of 
calcium spikes, while dibromoethane (p = 0.9744) galanthamine (p = 0.9895) and propoxur (p = 0.9999) were 
comparable with the control treatment.
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expression inappropriate? To address this issue, we measured hspb11 transgene levels separately for both single 
tissues after chemical treatment (Fig. S3). In the absence of MS-222, azinphosmethyl, propoxur and veratridine 
treatment up-regulated hspb11 transgene in both single tissues more than 1.5-fold over negative controls (DMSO 
Figure 6. Chemical–or heat shock-induced up-regulation of hspb11 transgene expression is caused by 
muscle hyperactivity. (A) Chemical induction of hspb11 transgene expression. TgBAC(hspb11:GFP) embryos 
were treated with azinphosmethyl (APM), propoxur (PPX), galanthamine (GAL) or veratridine (VER) during 
9–48 hpf with negative controls of DMSO control (Ctrl) and dibromoethane (DBE), either in the absence 
or in the presence of MS-222. The hspb11 GFP reporter intensity in the trunk region is expressed as fold 
induction over DMSO control. In the absence of MS-222, a significant increase of hspb11 transgene expression 
in comparison to the DMSO control was observed (one-way ANOVA F[5, 82] = 40.732, p = 2.2 × 10−16) 
with azinphosmethyl (TukeyHSD, ***p = 0.0000000), propoxur (***p = 0.0000165), galanthamine 
(***p = 0.0007428), and veratridine (***p = 0.0000000). However, this was not the case in the presence of MS-
222 (F[5, 80] = 2.3075, p = 0.05185). Sample size is given in parenthesis as the number of embryos.  
(B–G’) Birefringence images of representative embryos from the experiment shown in panel (A) (lateral views, 
anterior left). (H–I’) Birefringence images of representative embryos from the experiment quantified in  
(J,J’) at 48 hpf treated with a heat shock (HS) of 1 hour at 37 °C in the absence (J) or the presence (J’) of MS-222. 
(J–J’) HS-mediated up-regulation of hspb11 transgene expression. TgBAC(hspb11:GFP) embryos at 48 hpf were 
treated either with HS (37 °C, 1 hour) or left untreated, and HS effects on hspb11 transgene expression were 
evaluated either in the absence or in the presence of MS-222. In the absence of MS-222, HS induced a significant 
increase of hspb11 transgene expression (Welch two-sample t-test; t = − 11.2483, ***p = 1.036 × 10−14). In 
contrast, no significant increase was observed in the presence of MS-222 (Welch two-sample t-test; t = 0.3744, 
p = 0.7098). Sample size is given in parenthesis as the number of embryos. Scale bars: 200 μm.
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and dibromoethane). Interestingly, the presence of MS-222 eliminated the up-regulation of hspb11 transgene 
both in the muscle and the notochord (Fig. S3). Thus, both muscular and notochordal hspb11 transgene are reg-
ulated by a similar mechanism. The notochord of amphioxus, a non-vertebrate chordate, is contractile and takes 
part in body movements together with myotomal muscles33. Thus, the vertebrate notochord may retain molecules 
common to the muscle, even though it is no longer contractile. Functional studies on the role of hspb11 in the 
notochord are pending.
The TgBAC(hspb11:GFP) zebrafish biosensor described here provides an unique tool for detecting chemicals 
that induce muscle hyperactivity, thereby interfering with motor function. It provides a quantitative measure for 
muscle hyperactivity without time lapse analysis, featuring high signal-to-noise ratio, sensitivity and specific-
ity. A simple readout potentiates its use for increased throughput. Alternatively, the hspb11 sensor could easily 
be combined with the Ca2+ sensor by simply crossing differently coloured transgenic reporters into one line. 
Automated measurements of these fluorescent readouts combined with the measurements of altered behavioural 
effects such as the motor response (e.g. vibration stimulated34), the photomotor response35 or heart beat36 will 
provide a multi-parameter assessment of the toxicological impact of compounds. This set-up will provide, in a 
single assay, insights into toxicological effects far beyond what can currently be achieved in cell culture or in vitro 
organ systems. As all these measurements can be carried out with zebrafish embryos, these assays will contribute 
to the principle of the 3Rs for ethical use of animals in testing (Replacement, Reduction and Refinement37) and at 
the same time satisfy the demands of the REACH programme38.
Methods
Ethics statement. All zebrafish husbandry and experimental procedures were performed in accordance 
with the German animal protection standards and were approved by the Government of Baden-Württemberg, 
Regierungspräsidium Karlsruhe, Germany (Aktenzeichen 35-9185.64).
Fish Maintenance. Wild-type zebrafish ABO is an inbred line initially derived from an intercross between 
the AB and wtOX line. The wild-type zebrafish strains ABO, and transgenic zebrafish lines TgBAC(hspb11:GFP) 
and Tg(-[505–310]unc45b:GCaMP5A) were maintained on a 14 hr/10 hr light-dark cycle at 28.5 °C in a recircu-
lation systems (Schwarz Ltd., Göttingen, Germany) and fed with commercial food and in-house hatched brine 
shrimp as described39. Embryos were reared in embryo medium and staged according to Kimmel et al40.
Generation of TgBAC(hspb11:GFP) and Tg(-[505/-310]unc45b:GCaMP5A) transgenic fish. The 
zebrafish BAC clone for hspb11 (DKEY-30K6 (ID:1132288); Sequence ID: AL844141.7; 257634 bp) was pur-
chased from Source BioScience (Berlin, Germany). The modified target vector with homologous arms of hspb11, 
enhanced green fluorescent protein (GFP) and kanamycin resistance sequences was generated as previously 
described22. The subsequent insertion of the iTol2-amp cassette into the modified BAC DNA for Tol2 transpo-
sase mediated facilitated integration of the construct into the zebrafish genome was performed following Suster 
et al.24. The modification of BAC DNA was confirmed by PCR23, and the clones positive for GFP and Tol2 arms 
were selected for micro-injection with Tol2 transposase mRNA. Stable transgenic lines were identified by GFP 
expression in the out-crossed offspring from G0 founder fish (F1). Two positive F1 families derived from inde-
pendent G0 founders were further in-crossed to obtain homozygous transgene carriers (F2). For the experiments, 
F2 homozygous carriers were out-crossed to obtain identical genetic population with heterozygous transgene 
expression. For the generation of the muscle specific calcium sensor line Tg([-505/-310]unc45b:GCaMP5A), 
the 5′ -untranslated region (from the position − 505 to − 310 relative to the translation start site, designated as 
[− 505/− 310]) of the gene coding for myosin chaperon unc45b was used to drive the calcium sensor GCaMP5A 
cassette in a muscle specific manner. The expression vector [− 505/− 310]unc45b-GCaMP5A flanked by Tol2-sites 
was created using the Tol2-kit41. The expression vector (concentration 5 ng/μl) was co-injected with Tol2 trans-
posase mRNA (10 ng/μl) for genomic integration. The injected embryos (G0) were raised for identification of 
insertions.
Chemicals. The chemicals used in this study were purchased from Sigma-Aldrich: azinphosmethyl 
(O,O-dimethyl S-[(4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl]dithiophosphate; CAS# 86-50-0; dissolved in 
dimethylsulfoxide [DMSO]), propoxur (2-isopropoxyphenyl N-methylcarbamate; CAS# 114-26-1; dissolved 
in H2O), galanthamine ((4aS,6R,8aS)– 5,6,9,10,11,12– hexahydro– 3-methoxy –11-methy l–4aH –[1]ben-
zofuro[3a,3,2-ef] [2] benzazepin –6-ol; CAS# 357-70-0, dissolved in DMSO), chlorpyrifos (O,O-diethyl 
O-3,5,6-trichloropyridin-2-yl phosphorothioate; CAS# 2921-88-2, dissolved in ethyl alcohol [EtOH]), 
chlorophenol (4-chlorophenol; CAS# 106-48-9, dissolved in H2O), dibutylphthalate (di-n-butylphthalate; 
CAS# 84-74-2, dissolved in DMSO), veratridine ((3β ,4β ,16β )-4,12,14,16,17,20-hexahydroxy-4,9-epoxyce-
van-3yl 3,4-dimethoxybenzoate 3-veratroylveracevine; CAS# 71-62-5, dissolved in DMSO), flucythrinate 
(cyano(3-phenoxyphenyl)methyl 2-[4-(difluoromethoxy)phenyl]-3-methylbutanoate; CAS# 70124-77-5, dis-
solved in EtOH), methoxychlor (1,1,1-trichloro-2,2-bis(4-methoxyphenyl)ethane; CAS# 72-43-5, dissolved in 
EtOH), esfenvalerate ((S)-cyano (3-phenoxyphenyl) methyl-(S)-4-chloro-alpha-(1-methylethyl); CAS# 66230-
04-4, dissolved in EtOH), methylmercury (methylmercury(II) chloride; CAS# 115-09-3, dissolved in H2O), 
dibromoethane (1,2− dibromoethane, CAS# 106-93-4, dissolved in H2O), dimethylphenol (2,4-dimethylphenol, 
CAS# 105-67-9, dissolved in H2O), chlorothalonil (2,4,5,6-tetrachloroisophthalonitrile; CAS# 1897-45-6, dis-
solved in DMSO) and MS-222 (tricaine methanesulfonate; ethyl 3-aminobenzoate methanesulfonate; CAS# 886-
86-2, dissolved in H2O).
Chemical treatment. Embryos were collected and raised in embryo medium39 until 6 hpf (hours post fer-
tilization). The fertilized embryos were selected and arranged in a 6-well polystyrene plate. Exposure of embryos 
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to chemicals with desired concentrations was performed from 9–48 hpf in embryo medium with 0.003% phen-
ylthiourea (N-phenylthiourea; PTU) for preventing the formation of pigmentation. In dose response experiments 
for chemicals, embryos were treated in various concentrations between 0.01 μM to 3 mM. Final solvent (DMSO 
and EtOH) concentrations were never higher than 0.1%. Embryos were manually dechorionated at 48 hpf before 
imaging. The experiment was performed in three biological repeats with at least 10 embryos at each dose from a 
series of concentrations.
Heat shock treatment. For the heat shock experiment, TgBAC(hspb11:GFP) transgenic embryos at 48 hpf 
were divided into 4 groups of 20–30 embryos each in the 2 ml tubes, filled with 1 ml of fish water. In two of the 
tubes the anaesthetic agent MS-222 was added at 643 μM, while the other two were kept as MS-222 negative. The 
temperature of the water bath was set to 37 °C and the heat shock was given for 1-hour to two groups of embryos, 
one with MS-222 and another without. The other pair of two groups, with or without MS-222, was kept at room 
temperature. After 4–5 hours post heat shock, images were taken under a compound microscope to quantify 
hspb11 transgene levels and to investigate the effects on muscle integrity by examining birefringence.
Scoring for lethality and abnormal motility. The embryos were examined for motility and lethality at 48 
hpf. Abnormal motility includes continuous twitch or shivering movements in the absence of touch stimuli, and 
lack of escape behaviour upon touch stimuli with the tip of a hair at the trunk. The experiment was performed in 
three biological repeats with at least 10 embryos each. Lethality was scored by lack of heart beat and coagulated 
bodies in a separate set of three experiments with at least 12 embryos each.
Detection of birefringence. Muscle integrity was observed under the compound microscope DM5000 
with a 5 × objective using polarized light42. Control and treated embryos were rotated in a way that a maximum 
amount of light could pass through the muscle fibres. Exposure time was set to 5.63 ms, gamma was 1.13 and gain 
was 4.0.
In situ gene expression analysis and histology. Whole-mount in situ hybridisation was performed 
as described43, with minor modification. Briefly, fixed embryos were treated with chilled acetone at − 20 °C for 
7 minutes to enhance tissue penetration of digoxygenin-labelled anti-sense ribonucleic acid probes. Hybridisation 
was performed at 65 °C in the presence of 1 mM EDTA to block endogenous alkaline phosphatase activity. After 
colour development with bromo-4-chloro-3-indolyl phosphate (BCIP, Roche) and nitroblue tetrazolium chloride 
(NBT, Roche), embryos were embedded into epoxy resins and 5 μm thick transverse sections were cut at the level 
of trunk as described44.
Algorithmic Parameters and Statistical Analysis. The dechorionated embryos were mounted in 3% 
methyl cellulose with dorsal up. Images were taken at 48 hpf using a Leica compound microscope DM5000 
under a 10 × objective. Exposure time was set to 880 ms for optimal visualization. The remaining parameters, 
i.e., gamma, saturation and gain were set to 1:18, 1:5 and 4.6, respectively. For each embryo, a single RGB image 
of the hspb11 reporter GFP signal was captured at a resolution of 1392 × 1040 pixels (px) with a physical spacing 
of 1 px = 0.32 μm. All acquired images were converted into a grey scale for further processing as described25, with 
minor parameter adjustments to adapt the processing steps to the different image contents (Gaussian-smoothing 
with a standard deviation of σ = 10 and region of interest extraction with a radius of r = 350 px). Global statistical 
values such as minimum, maximum, median, mean and standard deviation of intensity values were extracted 
from the linearized and cropped original image. All algorithms were implemented in MATLAB as an extension 
package to the open-source MATLAB toolbox Gait-CAD45. To evaluate whether there is an effect of a test chemi-
cal on the hspb11 reporter level, the differences of the hspb11 reporter level among doses including solvent control 
were examined by one-way ANOVA with a significance threshold of p < 0.001. Chemicals with significant effects 
were modelled for their concentration dependent responses using a Gaussian 4-parameter logarithmic model 
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The coefficient c was set to 1 due to the prior normalisation. b, d and e were fitted using the program jmp 
11.1.1. (SAS, Böblingen, Germany). Subsequently, the concentrations (x) leading to a 1.5 (y) induction were 
calculated (EC1.5). The effect level of 1.5-fold was selected based on the average control variability. In case of 
methylmercury, dibutylphthalate, methoxychlor and 4-chlorophenol, no Gaussian like concentration-response 
was observed and the 1.5-fold induction levels were estimated from a linear regression model47.
Confocal time lapse analysis. 2-dpf transgenic embryos Tg([-505/-310]unc45b:GCaMP5A) were embed-
ded into 0.5% low-melting agarose prepared with 50 mM HEPES pH 7.0/ 5 mM NaCl/ 0.17 mM KCl/ 0.33 mM 
CaCl2/ 0.33 mM MgSO4. Each chemical treatment (dibromoethane at 2.1 mM, azinphosmethyl at 1 μM, propoxur 
at 720 μM, galanthamine at 1 mM and veratridine at 120 μM) was accompanied by solvent control (0.5% DMSO) 
in a home-made imaging chamber with two isolated slots. No anaesthetic chemical was added. A Leica TCS SP5 
upright confocal microscope was used in resonant scanning mode (bidirectional scanning at 8000 Hz) to achieve 
a time resolution of 2.5 minutes with a 2 μm z-step size for up to 12 embryos for 16 hours. A HCX PL APO lambda 
blue 20x NA0.70 IMM UV objective was used with glycerol as immersion medium. Temperature control was set 
to 28 °C. Data were processed with ImageJ/Fiji48.
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